Trend Coins: Ethereum ecosystem projects (ETHFI, PEPE, ENA)
1. Eric Balchunas, senior ETF analyst at Bloomberg, said in a post that the US SEC finally responded to the issuer, asking them to submit the final S-1 form (including fees) this Wednesday, and then apply for it to take effect after the close of next Monday, so that it can be launched on Tuesday (July 23). This means that the listing date of ETH ETF has been determined.
2. According to CME "Federal Reserve Watch": The probability of the Federal Reserve keeping interest rates unchanged in August is 94.3%, and the probability of a 25 basis point interest rate cut is 5.7%. At the same time, expectations for a rate cut in September have increased.
3. At present, the trading volume and price of ETHFI, PEPE, and ENA have soared, and the token prices have risen by 10.57%, 27.99%, and 17.62% in 24 hours.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
A key leap toward the internationalization of the Korean won: The Bank of Korea launches a trial run of its 24/7 international settlement system, with full deployment set for January next year.
The Bank of Korea officially launched the trial operation of the "BOK Won International Payment Network" on Monday local time.
Offshore oil and gas module equipment company VME (VME.US) aiming for Nasdaq listing, plans to raise up to 30 million USD
Offshore oil and gas process module and separation equipment company VME Companies has applied for an IPO on Nasdaq, aiming to raise up to $30 million, with Kingswood as the sole bookrunner.
Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.
U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).
Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential
According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.
Crypto prices
More
